Flipped Classroom Approach in Continuous Ambulatory Peritoneal Dialysis Training
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jan 14, 2024
Trial Information
Current as of July 15, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to teach patients with Chronic Kidney Disease (CKD) about managing their health, specifically focusing on a treatment called Continuous Ambulatory Peritoneal Dialysis (CAPD). The researchers want to find out if using a “flipped classroom” approach—where patients learn through videos and self-study before attending face-to-face sessions—helps them understand their treatment better compared to traditional teaching methods.
To participate in this study, you need to be at least 18 years old and have CKD Stage 5, which means your kidneys are not functioning well. You should also be able to learn and practice the CAPD techniques, and it’s important that you can communicate in Cantonese and use electronic devices to access online materials. Participants will spend a week engaging in various learning activities, including watching instructional videos and participating in group sessions. This trial aims to see if this new teaching method can improve patients’ ability to manage their kidney disease effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The candidates should meet the below criteria will be recruited.
- • 1. age ≥ 18 years
- • 2. clinically diagnosed to have CKD Stage 5 (estimated creatinine clearance - 15 mL/min/1.73 m2)
- • 3. Tenkoff insertion was performed and CAPD training will be offered in 4 weeks
- • 4. able to perform self-care CAPD or family-assisted CAPD
- • 5. willing to participate in audio-visual assisted and face-to-face activities
- • 6. alert and oriented, able to sustain for approximately one hour of attention and interaction
- • 7. communicable in Cantonese, able to read and write Chinese
- • 8. could be reached by phone and able to use electronic devices, e.g. smart phone, tablet, notebook or computers to access online audio-visual materials
- Exclusion Criteria:
- • Patients having one or above of the below conditions will be excluded from the study.
- • 1. patients who have been receiving dialysis therapy
- • 2. patients who are unable to communicate in Cantonese
- • 3. patient who has hearing deficit
- • 4. patient who are disoriented, delirious or cognitively impaired
- • 5. patients who are clinically depressed diagnosed by medical doctors
- • 6. patients who do not have access to online material using electronic devices
- • 7. patients who are incompetent in giving written consent
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hung Hom, Hong Kong Island, Hong Kong
Patients applied
Trial Officials
Kitty Chan, PhD
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported